IBAC stock news
This page provides real-time market news, earnings updates, and company announcements related to IB Acquisition Corp. (IBAC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-30 11:33 EST
Top Stock Reports for Micron Technology, Goldman Sachs & Verizon
Finviz2026-02-13 23:03:07
RIGL Stock Rises 59% in a Year: Time to Buy, Hold or Sell?
Finviz2026-02-16 15:03:11
KeyCorp (KEY) Up 1.2% Since Last Earnings Report: Can It Continue?
Finviz2026-02-19 17:33:45
JPM Signals IB Strength, NII Growth & Tech Spending Jump in 2026
Finviz2026-02-24 17:18:07
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Kymera Q4 Loss Exceeds Projections, Additional Funding Prolongs Financial Runway
101 finance2026-02-27 15:39:46
Top Stock Reports for NVIDIA, Microsoft & JPMorgan
Finviz2026-02-27 22:57:48
礼来惊吓，诺和诺德救场！减肥药市场前景依旧令众玩家垂涎
moomoo-证劵2026-03-01 14:19:20
The Zacks Analyst Blog Highlights NVIDIA, Microsoft , JPMorgan Chase, Star Group and Coffee Holding
Finviz2026-03-02 10:42:47
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity
Finviz2026-03-10 00:13:05
Bank of America Confronts First Quarter NII Challenge as Investors Factor in Robust Forecast
101 finance2026-03-10 18:33:40
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Top Analyst Reports for Philip Morris, Lam Research, and Goldman Sachs
101 finance2026-03-16 22:03:51
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
SRPT Stock Rises as DMD Gene Therapy Safety Trial Kicks Off
101 finance2026-03-17 15:43:06
Serina Therapeutics Hinges on Q3 Safety Review as POZ Platform's First Clinical Test
101 finance2026-03-18 20:39:49
Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Finviz2026-03-19 12:04:20
Neuraxis Inc's Revenue Inflection Timing and PA Approval Rates Don't Match
101 finance2026-03-19 15:28:14
Prothena’s anticipated Phase III launch in 2026 reinforces the progress of the alpha-synuclein and amyloid S-curve trajectory
101 finance2026-03-21 20:39:48
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion
101 finance2026-03-24 16:15:36
Top Equity Analysis for Amazon.com, TJX, and Eaton Corp.
101 finance2026-03-25 22:09:34
IBAC’s Deadline Extension Hides a Mispricing: Stock Trades Below Redemption Value as $500M Deal Clock Ticks
101 finance2026-03-27 21:42:50
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Kymera Q4 Loss Exceeds Projections, Additional Funding Prolongs Financial Runway
101 finance2026-02-27 15:39:46
Top Stock Reports for NVIDIA, Microsoft & JPMorgan
Finviz2026-02-27 22:57:48
礼来惊吓，诺和诺德救场！减肥药市场前景依旧令众玩家垂涎
moomoo-证劵2026-03-01 14:19:20
The Zacks Analyst Blog Highlights NVIDIA, Microsoft , JPMorgan Chase, Star Group and Coffee Holding
Finviz2026-03-02 10:42:47
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity
Finviz2026-03-10 00:13:05
Bank of America Confronts First Quarter NII Challenge as Investors Factor in Robust Forecast
101 finance2026-03-10 18:33:40
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Top Analyst Reports for Philip Morris, Lam Research, and Goldman Sachs
101 finance2026-03-16 22:03:51
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
SRPT Stock Rises as DMD Gene Therapy Safety Trial Kicks Off
101 finance2026-03-17 15:43:06
Serina Therapeutics Hinges on Q3 Safety Review as POZ Platform's First Clinical Test
101 finance2026-03-18 20:39:49
Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Finviz2026-03-19 12:04:20
Neuraxis Inc's Revenue Inflection Timing and PA Approval Rates Don't Match
101 finance2026-03-19 15:28:14
Prothena’s anticipated Phase III launch in 2026 reinforces the progress of the alpha-synuclein and amyloid S-curve trajectory
101 finance2026-03-21 20:39:48
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion
101 finance2026-03-24 16:15:36
Top Equity Analysis for Amazon.com, TJX, and Eaton Corp.
101 finance2026-03-25 22:09:34
IBAC’s Deadline Extension Hides a Mispricing: Stock Trades Below Redemption Value as $500M Deal Clock Ticks
101 finance2026-03-27 21:42:50
IBAC stock chart
IBAC stock detailsIBAC stock price change
On the last trading day, IBAC stock closed at 10.66 USD, with a price change of -0.19% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more